Tapewire

NYSE · USD

AIM

AIM ImmunoTech Inc.

Export transactions ↓
Tapewire entity
8131
SEC CIK
0000946644
Parsed reports
303

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202640
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 27, 2018 Filed Nov 29, 2018 15:34 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001613377-18-000036 · primary_doc.xml · nonDerivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 778,307

F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019.

Read SEC document
November 27, 2018 Filed Nov 29, 2018 15:11 UTC
STRAYER DAVID RChief Science/Medical Officer
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001613377-18-000035 · primary_doc.xml · nonDerivative · entry 1

STRAYER DAVID R · CIK 0001270074 · Chief Science/Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,304

F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019.

Read SEC document
November 27, 2018 Filed Nov 29, 2018 14:20 UTC GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001613377-18-000033 · primary_doc.xml · nonDerivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,148

F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019.

Read SEC document
November 27, 2018 Filed Nov 29, 2018 14:42 UTC
SPRINGATE WAYNE SSr. VP of Operations
GrantCommon Stock 2,500 $0.00 $0.00
Disclosure

SEC source: 0001613377-18-000034 · primary_doc.xml · nonDerivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,273

F1 · kind: The Board of Directors awarded 2,500 shares of Company common stock to each employee, executive, and board member as a holiday bonus to be issued after January 2, 2019.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 17:16 UTC
Rodino Peter W IIIDir Govt Relations/Sectry
GrantOptions to buy Common Stock · Derivative 1,000 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000032 · primary_doc.xml · derivative · entry 1

RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2028-11-14

F1 · security: This option has been awarded by the Board of Directors.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 16:38 UTC
SPRINGATE WAYNE SSr. VP of Operations
GrantOptions to buy Common Stock · Derivative 1,000 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000030 · primary_doc.xml · derivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2028-11-14

F1 · security: This option has been awarded by the Board of Directors.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 16:55 UTC
STRAYER DAVID RChief Science/Medical Officer
GrantOptions to buy Common Stock · Derivative 1,000 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000031 · primary_doc.xml · derivative · entry 1

STRAYER DAVID R · CIK 0001270074 · Chief Science/Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2028-11-14

F1 · security: This option has been awarded by the Board of Directors.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 16:22 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantOptions to buy Common Stock · Derivative 1,000 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000029 · primary_doc.xml · derivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2028-11-14

F1 · security: This option has been awarded by the Board of Directors.

Read SEC document
November 14, 2018 Filed Nov 16, 2018 15:55 UTC GrantOptions to buy Common Stock · Derivative 1,000 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000028 · primary_doc.xml · derivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,000

Underlying: Common Stock · 1,000 shares

Expires 2028-11-14

F1 · security: This option has been awarded by the Board of Directors.

Read SEC document
November 05, 2018 Filed Nov 6, 2018 16:24 UTC PurchaseCommon Stock 25,238 $0.22 $5,552.36
Disclosure

SEC source: 0001702626-18-000005 · primary_doc.xml · nonDerivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,988

Read SEC document
October 26, 2018 Filed Oct 29, 2018 13:14 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
PurchaseCommon Stock 3,500 $0.20 $710.50
Disclosure

SEC source: 0001450324-18-000007 · primary_doc.xml · nonDerivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 775,807

Read SEC document
October 25, 2018 Filed Oct 25, 2018 13:22 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
PurchaseCommon Stock 100,000 $0.20 $20,000.00
Disclosure

SEC source: 0001450324-18-000006 · primary_doc.xml · nonDerivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 772,307

Read SEC document
October 17, 2018 Filed Oct 19, 2018 16:08 UTC
SPRINGATE WAYNE SSr. VP of Operations
GrantOptions to buy Common Stock · Derivative 94,697 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000023 · primary_doc.xml · derivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,697

Underlying: Common Stock · 94,697 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Read SEC document
October 17, 2018 Filed Oct 19, 2018 15:24 UTC
STRAYER DAVID RChief Science/Medical Officer
GrantOptions to buy Common Stock · Derivative 123,106 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000022 · primary_doc.xml · derivative · entry 1

STRAYER DAVID R · CIK 0001270074 · Chief Science/Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 123,106

Underlying: Common Stock · 123,106 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Read SEC document
October 17, 2018 Filed Oct 19, 2018 17:12 UTC GrantOptions to buy Common Stock · Derivative 172,786 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000027 · primary_doc.xml · derivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,786

Underlying: Common Stock · 172,786 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Director's fees.

Read SEC document
October 17, 2018 Filed Oct 19, 2018 17:00 UTC GrantOptions to buy Common Stock · Derivative 172,786 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000026 · primary_doc.xml · derivative · entry 1

MITCHELL WILLIAM M · CIK 0001191434 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,786

Underlying: Common Stock · 172,786 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Director's fees.

Read SEC document
October 17, 2018 Filed Oct 19, 2018 16:46 UTC
Rodino Peter W IIIDir Govt Relations/Sectry
GrantOptions to buy Common Stock · Derivative 132,576 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000025 · primary_doc.xml · derivative · entry 1

RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 132,576

Underlying: Common Stock · 132,576 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Read SEC document
October 17, 2018 Filed Oct 19, 2018 16:31 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantOptions to buy Common Stock · Derivative 284,091 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000024 · primary_doc.xml · derivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,091

Underlying: Common Stock · 284,091 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Read SEC document
October 17, 2018 Filed Oct 19, 2018 14:57 UTC GrantOptions to buy Common Stock · Derivative 94,697 $0.00 Strike: $0.22 $0.00
Disclosure

SEC source: 0001613377-18-000021 · primary_doc.xml · derivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,697

Underlying: Common Stock · 94,697 shares

Expires 2028-10-17

F1 · security: This option is being issued to senior management in exchange for a voluntary 50% deferral in salary.

Read SEC document
October 17, 2018 Filed Oct 17, 2019 21:06 UTC OtherCommon Stock 6,911 $0.55 $3,801.05
Disclosure

SEC source: 0001450324-19-000016 · primary_doc.xml · nonDerivative · entry 1

MITCHELL WILLIAM M · CIK 0001191434 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,679

F1 · kind: Shares issued for 50 percent of Director's Fee for the first half of October, 2019.

Read SEC document
July 27, 2018 Filed Jul 27, 2018 13:31 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
PurchaseCommon Stock 34,483 $0.29 $10,000.07
Disclosure

SEC source: 0001450324-18-000005 · primary_doc.xml · nonDerivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 672,306

Read SEC document
July 24, 2018 Filed Jul 24, 2018 13:24 UTC PurchaseCommon Stock 126,000 $0.31 $39,060.00
Disclosure

SEC source: 0001702626-18-000004 · primary_doc.xml · nonDerivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,750

Read SEC document
July 23, 2018 Filed Jul 23, 2018 14:49 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
PurchaseCommon Stock 112,904 $0.31 $35,000.24
Disclosure

SEC source: 0001613377-18-000020 · primary_doc.xml · nonDerivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 637,823

Read SEC document
July 23, 2018 Filed Jul 23, 2018 14:06 UTC
SPRINGATE WAYNE SSr. VP of Operations
PurchaseCommon Stock 32,259 $0.31 $10,000.29
Disclosure

SEC source: 0001613377-18-000019 · primary_doc.xml · nonDerivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,773

Read SEC document
July 23, 2018 Filed Jul 23, 2018 13:32 UTC PurchaseCommon Stock 32,259 $0.31 $10,000.29
Disclosure

SEC source: 0001613377-18-000017 · primary_doc.xml · nonDerivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,648

Read SEC document
July 18, 2018 Filed Jul 19, 2018 17:50 UTC
Rodino Peter W IIIDir Govt Relations/Sectry
GrantOptions to buy Common Stock · Derivative 75,269 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001613377-18-000013 · primary_doc.xml · derivative · entry 1

RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,269

Underlying: Common Stock · 75,269 shares

Expires 2028-07-18

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
July 18, 2018 Filed Jul 19, 2018 18:41 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantOptions to buy Common Stock · Derivative 161,290 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001450324-18-000004 · primary_doc.xml · derivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 161,290

Underlying: Common Stock · 161,290 shares

Expires 2028-07-18

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
July 18, 2018 Filed Jul 19, 2018 15:57 UTC
SPRINGATE WAYNE SSr. VP of Operations
GrantOptions to Buy Common Stock · Derivative 53,763 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001465652-18-000009 · primary_doc.xml · derivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,763

Underlying: Common Stock · 53,763 shares

Expires 2028-07-18

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
July 18, 2018 Filed Jul 19, 2018 16:50 UTC GrantOptions to buy Common Stock · Derivative 53,763 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001613377-18-000012 · primary_doc.xml · derivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,763

Underlying: Common Stock · 53,763 shares

Expires 2028-07-18

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
July 18, 2018 Filed Jul 20, 2018 14:48 UTC GrantOptions to buy Common Stock · Derivative 98,098 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001613377-18-000016 · primary_doc.xml · derivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,098

Underlying: Common Stock · 98,098 shares

Expires 2028-07-18

F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Directors Fees.

Read SEC document
July 18, 2018 Filed Jul 20, 2018 14:11 UTC GrantOptions to buy Common Stock · Derivative 98,098 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001613377-18-000015 · primary_doc.xml · derivative · entry 1

MITCHELL WILLIAM M · CIK 0001191434 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,098

Underlying: Common Stock · 98,098 shares

Expires 2028-07-18

F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Directors fees.

Read SEC document
May 16, 2018 Filed May 18, 2018 16:15 UTC GrantOptions to buy Common Stock · Derivative 100,000 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000011 · primary_doc.xml · derivative · entry 2

MITCHELL WILLIAM M · CIK 0001191434 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-05-16

F2 · security: This option was awarded by the Board of Directors for serving as chairman of various committees.

Read SEC document
May 16, 2018 Filed May 18, 2018 16:15 UTC GrantOptions to buy Common Stock · Derivative 152,053 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000011 · primary_doc.xml · derivative · entry 1

MITCHELL WILLIAM M · CIK 0001191434 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,053

Underlying: Common Stock · 152,053 shares

Expires 2028-05-16

F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Directors fees.

Read SEC document
May 16, 2018 Filed May 18, 2018 15:13 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
OtherOptions to buy Common Stock · Derivative 300,000 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000009 · primary_doc.xml · derivative · entry 2

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 795,833

Underlying: Common Stock · 300,000 shares

Expires 2028-05-16

F2 · security: Stock options issued per the employment agreement.

Read SEC document
May 16, 2018 Filed May 18, 2018 15:13 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantOptions to buy Common Stock · Derivative 250,000 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000009 · primary_doc.xml · derivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,000

Underlying: Common Stock · 250,000 shares

Expires 2028-05-16

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
May 16, 2018 Filed May 18, 2018 15:56 UTC GrantOptions to buy Common Stock · Derivative 100,000 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000010 · primary_doc.xml · derivative · entry 2

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-05-16

F2 · security: This option was awarded by the Board of Directors for serving as chairman of various committees.

Read SEC document
May 16, 2018 Filed May 18, 2018 15:56 UTC GrantOptions to buy Common Stock · Derivative 152,053 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000010 · primary_doc.xml · derivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 152,053

Underlying: Common Stock · 152,053 shares

Expires 2028-05-16

F1 · security: This option is being issued to senior management for a voluntary 100% deferral of Directors fees.

Read SEC document
May 16, 2018 Filed May 18, 2018 14:15 UTC
SPRINGATE WAYNE SSr. VP of Operations
GrantOptions to buy Common Stock · Derivative 79,167 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000007 · primary_doc.xml · derivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,167

Underlying: Common Stock · 79,167 shares

Expires 2028-05-16

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
May 16, 2018 Filed May 18, 2018 14:35 UTC
Rodino Peter W IIIDir Govt Relations/Sectry
GrantOptions to buy Common Stock · Derivative 116,667 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000008 · primary_doc.xml · derivative · entry 1

RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,667

Underlying: Common Stock · 116,667 shares

Expires 2028-05-16

F1 · security: This option is being issued to Senior Management in exchange for a voluntary 40% deferral in salary.

Read SEC document
May 16, 2018 Filed May 18, 2018 13:57 UTC GrantOptions to buy Common Stock · Derivative 83,334 $0.00 Strike: $0.30 $0.00
Disclosure

SEC source: 0001613377-18-000006 · primary_doc.xml · derivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,334

Underlying: Common Stock · 83,334 shares

Expires 2028-05-16

F1 · security: This option is being issued to senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document
April 27, 2018 Filed Apr 30, 2018 10:37 UTC PurchaseCommon Stock 100,000 $0.32 $32,000.00
Disclosure

SEC source: 0001702626-18-000002 · primary_doc.xml · nonDerivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,750

Read SEC document
April 27, 2018 Filed Apr 30, 2018 10:22 UTC
Equels Thomas KDirector · CEO, President
PurchaseCommon Stock 32,000 $0.32 $10,240.00
Disclosure

SEC source: 0001450324-18-000002 · primary_doc.xml · nonDerivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · CEO, President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 524,919

Read SEC document
April 12, 2018 Filed Apr 19, 2018 19:34 UTC GrantOptions to buy Common Stock · Derivative 100,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000008 · primary_doc.xml · derivative · entry 1

MITCHELL WILLIAM M · CIK 0001191434 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
April 12, 2018 Filed Apr 19, 2018 19:01 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantOptions to buy Common Stock · Derivative 125,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000006 · primary_doc.xml · derivative · entry 1

EQUELS THOMAS K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
April 12, 2018 Filed Apr 19, 2018 19:22 UTC GrantOptions to buy Common Stock · Derivative 100,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000007 · primary_doc.xml · derivative · entry 1

APPELROUTH STEWART · CIK 0001702626 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
April 12, 2018 Filed Apr 19, 2018 17:46 UTC
STRAYER DAVID RChief Science/Medical Officer
GrantOptions to buy Common Stock · Derivative 75,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000004 · primary_doc.xml · derivative · entry 1

STRAYER DAVID R · CIK 0001270074 · Chief Science/Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
April 12, 2018 Filed Apr 19, 2018 18:09 UTC
Rodino Peter W IIIDir Govt Relations/Sectry
GrantOptions to buy Common Stock · Derivative 100,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000005 · primary_doc.xml · derivative · entry 1

RODINO III PETER W. · CIK 0001583701 · Dir Govt Relations/Sectry

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
April 12, 2018 Filed Apr 19, 2018 17:31 UTC GrantOptions to buy Common Stock · Derivative 75,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000003 · primary_doc.xml · derivative · entry 1

PASCALE ADAM · CIK 0001613377 · CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
April 12, 2018 Filed Apr 19, 2018 17:17 UTC
SPRINGATE WAYNE SSr. VP of Operations
GrantOptions to buy Common Stock · Derivative 75,000 $0.00 Strike: $0.38 $0.00
Disclosure

SEC source: 0001465652-18-000002 · primary_doc.xml · derivative · entry 1

SPRINGATE WAYNE S · CIK 0001465652 · Sr. VP of Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2028-04-12

F1 · security: This option is being awarded by the Board of Directors.

Read SEC document
February 13, 2018 Filed Mar 1, 2018 20:12 UTC
Equels Thomas KDirector · Exec. Vice Chairman/CEO/Pres.
GrantOptions to buy Common Stock · Derivative 371,622 $0.00 Strike: $0.37 $0.00
Disclosure

SEC source: 0001191434-18-000002 · primary_doc.xml · derivative · entry 1

Equels Thomas K. · CIK 0001450324 · Director · Exec. Vice Chairman/CEO/Pres.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 371,622

Underlying: Common Stock · 371,622 shares

Expires 2028-02-13

F1 · security: This option is being issued by senior management in exchange for a voluntary 40% deferral in salary.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.